K&F’s first post-pandemic jury trial resulted in a $10.6 million verdict for the widow of a mesothelioma victim.

Pharmaceutical Litigation

4 U.S. companies will pay $26 billion to settle claims they fueled the opioid crisis

On Behalf of John Murphy | Mar 10, 2022 | Opioid Epidemic, Pharmaceutical Litigation

The price tag of manufacturing an opioid crisis that led to the deaths of thousands of Americans in Ohio and nationwide is $26 billion. Four pharmaceutical giants have consented to pay this amount to settle the mountain of lawsuits lodged against them. Johnson &...

Defective medical devices and drugs recalled

On Behalf of John Murphy | Jan 19, 2021 | Pharmaceutical Litigation, Products Liability

Many Ohio residents trust their doctors regarding the use of medication and medical devices. However, each year, the Food and Drug Administration determines that some medicines and medical devices pose risks that make them unacceptable for patients to use. The...

Food and Drug Administration recalls diabetes drug

On Behalf of John Murphy | Oct 21, 2020 | Pharmaceutical Litigation

For those in Ohio and across the country who struggle with diabetes, maintaining a healthy glucose level is essential. High glucose levels can lead to serious complications, and many with diabetes rely on medications to help them regulate those levels and remain...

FDA releases guidelines to curb nizatidine drug injuries

On Behalf of John Murphy | Oct 2, 2020 | Pharmaceutical Litigation

Cancer causing substances can show up in the most surprising places. One place most people in Ohio do not want those substances showing up is in their prescription medications. But the carcinogen N-nitrosodimethylamine -- NDMA -- has been found in a number of...

Janssen Pharmaceuticals hid Elmiron drug injuries information

On Behalf of John Murphy | Sep 17, 2020 | Pharmaceutical Litigation

Living with a chronic health condition can be debilitating. Unfortunately for some people in Ohio, the medications prescribed for these conditions end up causing drug injuries far more harmful than the conditions themselves. This is often the result of pharmaceutical...

Drug injuries: Is a pharmaceutical company liable in your case?

On Behalf of John Murphy | Sep 7, 2020 | Pharmaceutical Litigation

Millions of people in Ohio and across the country take prescription drugs. There are numerous reasons why a physician might prescribe a specific medication for a patient. When a person suffers drug injuries, it sometimes results in litigation against the...

Mislabeled medications could cause drug injuries

On Behalf of John Murphy | Sep 3, 2020 | Pharmaceutical Litigation

Living with a chronic disease can be difficult, but advancements in medicine and technology have made it possible for many people to live long, happy lives despite their health issues. However, without the correct medication and dosage, these same individuals can...

Purdue Pharma could pay $13 billion in pharmaceutical litigation

On Behalf of John Murphy | Aug 27, 2020 | Pharmaceutical Litigation

Pharmaceutical companies may act as if they are on the side of the consumers, doing their best to provide the safest medications to help them live the healthiest lives possible. Unfortunately, this is often not the case. Purdue Pharma may have to pay $13 billion in...

Elmiron use linked to loss of vision: Are you at risk?

On Behalf of John Murphy | Aug 21, 2020 | Pharmaceutical Litigation

Three large pharmaceutical companies are facing multiple personal injury lawsuits from patients who used their medication Elmiron. The lawsuits claim the companies knew the medication could cause damage to patients' eyesight.These victims were all prescribed the...

Purdue Pharma faces $13 billion in penalties over opioid epidemic

On Behalf of John Murphy | Aug 13, 2020 | Pharmaceutical Litigation

In the midst of everything else going on across the country and here in Ohio, the Department of Justice continued pursuing justice against Purdue Pharma, which is a drug manufacturer. The drug in question is OxyContin, one of the drugs at the center of the country's...